This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Moleculera Labs, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services, University of Oklahoma. Active years: 2017-2019.
Company Filing History:
2 out of 2 
2 out of 3,690 
2 out of 575 
Years Active: 2017-2019
Title: Phina Madeleine Cunningham: Innovator in Pediatric Neuropsychiatric Diagnostics
Introduction
Phina Madeleine Cunningham is a notable inventor based in Oklahoma City, OK (US). She has made significant contributions to the field of pediatric neuropsychiatric disorders, particularly through her innovative diagnostic methods. With a total of 2 patents, her work is paving the way for better understanding and treatment of conditions such as pediatric acute-onset neuropsychiatric syndrome (PANS) and pediatric autoimmune neuropsychiatric disorder associated with streptococci infection (PANDAS).
Latest Patents
Cunningham's latest patents focus on a diagnostic method that utilizes a panel of at least five clinical analyses or tests using serum samples. These tests aim to determine the risk of PANS and/or PANDAS in individuals. The method includes enzyme-linked immunosorbent assays (ELISAs) to measure antibody titers against various neuronal antigens present in the brain. The neuronal antigens include lysoganglioside, tubulin, dopamine receptor D1, dopamine receptor D2, serotonin receptor 5HT2A, and serotonin receptor 5HT2C. The results from these analyses are combined using an algorithm to ascertain whether a PANS or PANDAS diagnosis is appropriate for the individual, thereby guiding appropriate treatment options.
Career Highlights
Throughout her career, Cunningham has worked with reputable organizations such as Moleculera Labs, Inc. and the University of Oklahoma. Her experience in these institutions has allowed her to collaborate with leading experts in the field, enhancing her research and innovation capabilities.
Collaborations
Some of her notable coworkers include Craig David Shimasaki and Susan E. Swedo, who have contributed to her work in pediatric neuropsychiatric diagnostics.
Conclusion
Phina Madeleine Cunningham's innovative approaches to diagnosing pediatric neuropsychiatric disorders are making a significant impact in the medical field. Her dedication to improving diagnostic methods is crucial for the treatment of affected children.